Principal Financial Group
BLCM

Principal Financial Group’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Principal Financial Group’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-54,978
Closed -$362K – 2471
2020
Q3 		$362K Buy
54,978
+1,740
+3% +$11.8K ﹤0.01% 2086
2020
Q2 		$396K Buy
+53,238
New +$362K ﹤0.01% 2023
2020
Q1 		– Sell
-50,315
Closed -$649K – 2267
2019
Q4 		$649K Buy
50,315
+14,049
+39% +$130K ﹤0.01% 1896
2019
Q3 		$381K Sell
36,266
-808
-2% -$10.6K ﹤0.01% 2006
2019
Q2 		$630K Buy
37,074
+1,331
+4% +$36K ﹤0.01% 1914
2019
Q1 		$1.2M Sell
35,743
-28
-0.1% -$936 ﹤0.01% 1804
2018
Q4 		$1.04M Buy
35,771
+74
+0.2% +$3.28K ﹤0.01% 1809
2018
Q3 		$2.2M Buy
35,697
+475
+1% +$32.2K ﹤0.01% 1750
2018
Q2 		$2.6M Buy
35,222
+19,212
+120% +$1.5M ﹤0.01% 1726
2018
Q1 		$1.05M Buy
16,010
+7,807
+95% +$590K ﹤0.01% 1815
2017
Q4 		$690K Sell
8,203
-307
-4% -$30.1K ﹤0.01% 1912
2017
Q3 		$983K Buy
8,510
+28
+0.3% +$2.95K ﹤0.01% 1830
2017
Q2 		$991K Buy
8,482
+148
+2% +$18.4K ﹤0.01% 1845
2017
Q1 		$1.03M Buy
8,334
+61
+0.7% +$7.99K ﹤0.01% 1816
2016
Q4 		$1.13M Buy
8,273
+304
+4% +$54K ﹤0.01% 1797
2016
Q3 		$1.59M Buy
7,969
+866
+12% +$149K ﹤0.01% 1707
2016
Q2 		$921K Sell
7,103
-100
-1% -$11.1K ﹤0.01% 1764
2016
Q1 		$674K Sell
7,203
-369
-5% -$40.2K ﹤0.01% 1783
2015
Q4 		$1.53M Buy
7,572
+14
+0.2% +$2.5K ﹤0.01% 1694
2015
Q3 		$1.1M Buy
7,558
+101
+1% +$18.5K ﹤0.01% 1752
2015
Q2 		$1.59M Buy
7,457
+471
+7% +$115K ﹤0.01% 1726
2015
Q1 		$1.62M Hold
6,986
– – ﹤0.01% 1693
2014
Q4 		$1.61M Buy
+6,986
New +$1.5M ﹤0.01% 1722

Other funds holding BLCM

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Principal Financial Group's BLCM Position: Q4 2020 in Review

Principal Financial Group sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q4 2020, closing a stake of 54,978 shares — an estimated $362K sold.

Principal Financial Group first reported a position in BLCM in Q4 2014 and held it in 23 quarters. The position peaked at $2.6M in Q2 2018. 34 funds tracked by Wall St. Rank hold BLCM as of Q4 2020.

  • Principal Financial Group reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Principal Financial Group sold 54,978 Bellicum Pharmaceuticals, Inc. shares in Q4 2020, an estimated $362K.
  • Principal Financial Group first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2014 and held it in 23 quarters.
  • Principal Financial Group's Bellicum Pharmaceuticals, Inc. position peaked at $2.6M in Q2 2018.
  • 34 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q4 2020.

Based on Principal Financial Group's 13F filing for Q4 2020, filed 8 Feb 2021.